RTI International hCB1/hCB2 compound 45

RTI International hCB1/hCB2 compound 45: sourced facts only. name: "Compound 45 is a partial agonist of CBRs with 50% Effective Concentration (EC50) of ∼150 nM at human (h)CB1 and 35 nM at hCB2 along with % Maximum Efficacy (Emax) of ∼32 at hCB1 and ∼17 at hCB2 respectively."; target: "Compound 45 is a partial agonist of CBRs with 50% Effective Concentration (EC50) of ∼150 nM at human (h)CB1 and 35 nM at hCB2 along with % Maximum Efficacy (Emax) of ∼32 at hCB1 and ∼17 at hCB2 respectively."; target: "Compound 45 is a partial agonist of CBRs with 50% Effective Concentration (EC50) of ∼150 nM at human (h)CB1 and 35 nM at hCB2 along with % Maximum Efficacy (Emax) of ∼32 at hCB1 and ∼17 at hCB2 respectively."; developer: "Discovery Sciences, RTI International, 3040 Cornwallis Rd., Durham, NC 27713, USA."